DENIS; Cecile

Patent Applications and Registrations

Patent applications and USPTO patent grants for DENIS; Cecile.The latest application filed is for "methods and pharmaceutical compositions for increasing endogenous protein level".

Company Profile

5.11.14

DENIS; Cecile - Le Kremlin-Bicetre FR
Denis; Cecile - Le Kremlin-Bic tre FR
DENIS; Cecile - Le Kremlin-Bicetre Cedex FR
DENIS; Cecile - Kremlin-Bic tre FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Pharmaceutical Compositions For Increasing Endogenous Protein Level App 20210277145 - LENTING; Peter ; et al.	2021-09-09
Mutated factor X polypeptides and uses thereof for the treatment of haemophilia Grant 11,085,032 - Christophe , et al. August 10, 2	2021-08-10
Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A Grant 10,851,176 - Bouton , et al. December 1, 2	2020-12-01
Mutated Factor X Polypeptides And Uses Thereof For The Treatment Of Haemophilia App 20200299666 - CHRISTOPHE; Olivier ; et al.	2020-09-24
Mutated Factor X Polypeptides And Uses Thereof For The Treatment Of Haemophilia App 20200248162 - Kind Code	2020-08-06
Anti-vwf D'd3 Single-domain Antibodies And Polypeptides Comprising Thereof App 20200207869 - LENTING; Petrus ; et al.	2020-07-02
Mutated factor X polypeptides and uses thereof for the treatment of haemophilia Grant 10,676,730 - Christophe , et al.	2020-06-09
Mutated factor X polypeptides and uses thereof for the treatment of haemophilia Grant 10,655,119 - Christophe , et al.	2020-05-19
Anti-VWF D'D3 single-domain antibodies and methods of use Grant 10,626,186 - Lenting , et al.	2020-04-21
Antibodies For The Prevention Or The Treatment Of Bleeding Episodes App 20200095335 - LENTING; Petrus ; et al.	2020-03-26
Antibodies for the prevention or the treatment of bleeding episodes Grant 10,544,231 - Lenting , et al. Ja	2020-01-28
Anti-antithrombin Single-domain Antibodies And Polypeptides Comprising Thereof App 20190100602 - LENTING; Peter ; et al.	2019-04-04
Anti-vwf D'd3 Single-domain Antibodies And Polypeptides Comprising Thereof App 20190085096 - LENTING; Petrus ; et al.	2019-03-21
Mutated Factor X Polypeptides And Uses Thereof For The Treatment Of Haemophilia App 20180334662 - CHRISTOPHE; Olivier ; et al.	2018-11-22
Methods And Pharmaceutical Compositions For Treatment Of Haemorrhagic Diseases App 20180105603 - BOUTON; Marie-Christine ; et al.	2018-04-19
Mutated Factor X Polypeptides And Uses Thereof For The Treatment Of Haemophilia App 20170369861 - CHRISTOPHE; Olivier ; et al.	2017-12-28
Antibodies For The Prevention Or The Treatment Of Bleeding Episodes App 20170037148 - LENTING; Petrus ; et al.	2017-02-09
Serene protease derivatives and uses in the prevention or the treatment of blood coagulation disorders Grant 8,741,286 - Christophe , et al. June 3, 2	2014-06-03
Serene Protease Derivatives and Uses in the Prevention or the Treatment of Blood Coagulation Disorders App 20130261060 - Christophe; Olivier ; et al.	2013-10-03
Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders Grant 8,518,400 - Christophe , et al. August 27, 2	2013-08-27
Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders Grant 8,436,144 - Christophe , et al. May 7, 2	2013-05-07
Serine Protease Derivatives And Uses In The Prevention Or The Treatment Of Blood Coagulation Disorders App 20130101570 - CHRISTOPHE; Olivier ; et al.	2013-04-25
Serine Protease Derivatives And Uses In The Prevention Or The Treatment Of Blood Coagulation Disorders App 20110293597 - Christophe; Olivier ; et al.	2011-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.